This study addresses the question of whether the cyclooxygenase inhibitors indomethacin and diclo fenac and the glucocorticosteroid dexamethasone ame liorate neuronal necrosis following cerebral ischemia. In addition, since these drugs inhibit the production of pros taglandins and depress phospholipase A2 activity, respec tively, the importance of free fatty acids (FFAs) on the development of ischemic neuronal damage was assessed. Neuronal damage was determined in the rat brain at I week following 10 min of forebrain ischemia. The cy c100xygenase inhibitors, whether given before or after ischemia, failed to alter the brain damage incurred. An imals given dexamethasone were divided into three groups and the drug was administered at a constant dosage of 2 mg/kg: (a) 2 days, 1 day, and 3 h intraperito neally before (chronic pretreatment), (b) 3 h intraperito neally before (acute pretreatment), and (c) 5 min intrave nously and 6 h and 1 day intraperitoneally after (chronic posttreatment) induction of ischemia. Acute pretreat ment did not affect the histopathological outcome.
ameliorated the damage inflicted on the caudate nucleus, but had no effect on other brain areas investigated. Unexpectedly, the chronic pretreatment aggravated the brain damage and caused seizures following ischemia.
Histopathological data showed massive neuronal damage in these brains. The accumulation of FFA levels during ischemia was markedly suppressed, and the decrease in the energy charge was curtailed by chronic pretreatment with dexamethasone. However, brain glucose levels in control animals and lactic acid concentrations following 10 min of ischemia were significantly higher both in the cerebral cortex and in the hippocampus of dexametha sone-treated animals. These results suggest that aggrava tion of neuronal necrosis by chronic dexamethasone pre treatment could be ascribed to lactic acidosis due to hyperglycemia in combination with an action of dexamethasone on glucocorticoid receptors in the brain.
Key Words: Cyclooxygenase-Dexamethasone-Free fatty acids-Hyperglycemia-Ischemic brain damage Lactic acidosis. be related to a perturbed phospholipid and fatty acid metabolism. The free fatty acids (FFAs), in particular arachidonic acid, released during isch emia have been suggested to participate in the dele terious reactions ultimately leading to neuronal damage (Bazan, 1970; Yoshida et aI. , 1980; Fishman and Chan, 1981; Siesj6, 1981) . Although polyenoic fatty acids are membrane active and po tentially toxic, it is usually assumed that the tox icity is expressed first when they are transformed to free radicals or other compounds, either nonen zymatically or in reactions catalyzed by cyclooxy genase and lipoxygenase (Egan et aI. , 1976; Wolfe, 1982; Ta ylor et aI. , 1983) .
In view of the potentially adverse effects of phospholipase activity during ischemia, it is natural that pharmacological interventions have been at tempted. The therapeutic basis of dexamethasone treatment is, at least in part, that the drug curtails the accumulation of FFAs by inhibiting phospholi pase A2 activity (Flower and Blackwell, 1979; Hirata et aI. , 1980) . Cyclooxygenase inhibitors are also potentially beneficial since they, by blocking the oxidative conversion of arachidonic acid to prostaglandins, also curtail the production of free radicals.
Although the effects of dexamethasone have been extensively explored in various models of brain trauma (Pappius, 1982) , tumor (Hossmann et aI. , 1983) , edema (Bremer et aI. , 1980; Fishman and Chan, 1981; Reid et aI. , 1983) , cerebral infarction (Plum et aI. , 1963; Barbosa-Coutinho et a\. , 1985) , and hypoxia (Temesvari et aI. , 1984) , the effective ness of the drug is still a matter of conjecture (Plum et aI. , 1963; Korbine, 1984) . Dexamethasone has a multiple mechanism of action. It intervenes in the pituitary-adrenal axis by modulating the release of stress hormones such as adrenocorticotropic hor mone and corticosterone (Axelrod and Reisine, 1984) , and in the brain it affects transmitter metabo lism and action (McEwen et aI. , 1979) and glial glu cose metabolism (DeVellis and Inglish, 1968) .
In this study, which is based on the quantitative assessment of brain damage, we carried out experi ments to evaluate whether dexamethasone or cy clooxygenase inhibitors ameliorate the neuronal necrosis following incomplete cerebral ischemia. However, none of the drugs used, whether given before or after ischemia, affected the outcome. Un expectedly, the data demonstrate that chronic dexamethasone pretreatment causes a massive in crease in neuronal damage. 
MATERIALS AND METHODS

Experimental groups
The animals were divided into 12 groups. For histopa thology, the following groups were studied: ischemic control (n = IS), dexamethasone chronic pretreatment (2 mg kg-I day i.p. 2 days, I day, and 3 h before ischemia) (n = 8), acute pretreatment (2 mg kg-I i.p. 3 h before ischemia) (n = 6), chronic posttreatment (2 mg kg -I i. v.
5 min and 6 h, and I day i.p. after ischemia) (n = 7), indomethacin acute pretreatment (5 mg kg-I i.v. 30 min before ischemia) (n = 6), and diclofenac acute pre-and posttreatment (30 mg kg-I i.v. 30 min before and 2 h after ischemia) (n = 6).
Studies of brain metabolism were performed in the fol-
lowing groups: normal control (n = 6), chronic dexa methasone treatment in normal animals (n = 6), ischemic control (n = 6), and chronic dexamethasone treatment in ischemic animals (n = 6). To study the effects of preischemic plasma glucose levels on brain metabolism during ischemia, animals were infused either with a phys iological Ringer's solution or with a 10% glucose solution (total volume 1-1.5 ml during the 30-min steady-state pe riod preceding the ischemia) (n = 6 in each) ( Table I) .
Operative procedures
The experiments were performed essentially as de scribed earlier (Smith et aI., 1984a, h) . All animals were fasted from 5 p.m. the day before induction of ischemia, but water was given ad libitum. On the day of the opera tion, anesthesia was induced with 3.0% halothane in a gas mixture with 30% O2 in N20. The trachea was intubated with a polyethylene tube (Intramedic PE 240; Clay Adams, Parsippany, NJ, U.S.A.) with the help of trans il lumination of the neck by a high-intensity fiberoptic lamp, and the animal was connected to a Sterling-type respirator and artificially ventilated. The jugular veins were exposed through a midline neck incision, and muscle relaxation was achieved with suxamethonium (5 mg kg-I i.v.) (Celocurin; Vitrum AB, Stockholm, Sweden). Anesthesia was maintained with 0.7% halo thane and 30% O2 in N20. A silicon catheter (Dow Corning Silastic; inner diameter 0.03 mm, outer diameter 0.065 mm) was inserted in the exposed right jugular vein for withdrawal of blood during the hypotension period (see following). Both common carotid arteries were ex posed, and the tail artery was cannulated (Portex PE 50; Hythe, Kent, England) to allow continuous blood pres sure recording and intermittent sampling of arterial blood. Needle electrodes were placed bilaterally through small skin incisions into the temporalis muscle to monitor the interhemispheric EEG during the ischemic period. The EEG amplitude was quantified with a cerebral func tion monitor (CFM) (Devices Ltd., Hertfordshire, En gland) on a semilogarithmic scale and a slow time base, frequencies outside the 2-to 16-Hz range being filtered out. Following these procedures, halothane was discon tinued and the rats were allowed 30 min to reach a steady-state period. Mechanical ventilation with 30% O2 in NP was continued throughout this period. Heparin (150 IU/kg) was administered intravenously. The initial blood gases and pH were sampled IS min following com pletion of the operative procedure and periodically there after. Samples were analyzed on a Combi-Analyzer (Eschweiler AG, Kiel, ER.G.) for Peo2 and Po2, and with a Radiometer (Copenhagen, Denmark) pH electrode and meter for pH.
This procedure was modified for animals prepared for analyses of energy metabolites and FFAs. Briefly, the dorsal skull was exposed and a plastic funnel was fitted into a skin incision for later use (Ponten et aI., 1973) . The brains were subsequently frozen in situ, removed, and stored at -80°C.
Induction of cerebral ischemia
Ischemia was induced with the forebrain model pre viously described in this laboratory (Smith et aI., 1984h) . Hypotension was induced with intravenous trimethaphan (2 mg kg-I) (Arfonad; Hoffmann-La Roche, Basel, Swit zerland) and rapid withdrawal of blood. When the mean arterial blood pressure reached 80 mm Hg, both common For histological evaluation 10-min ischemia (n = 15) 37. 1 ± 0.1 133 ± 2 37. 6 ± 0. 5 III ± 4 7. 38 ± 0.01 7. 1 ± 0.3 IO-min ischemia + dexamethasone chronic pretreatment (n = 8)
37.3 ± 0. 1 127 ± 3 37. 7 ± 0.9 106 ± 4 7.37 ± 0.01 11.3 ± 0.6a IO-min ischemia + dexamethasone acute pretreatment (n = 6) 37.3 ± 0. 1 130 ± 3 38. 7 ± 1.1 109 ± 3 7.38 ± 0.01 7.3 ± 0.5 10-min ischemia + dexamethasone chronic posttreatment (n = 8) 36. 9 ± 0.1 129 ± 3 35. 6 ± 0. 8 115 ± 5 7. 39 ± 0. 01 7.3 ± 0.5 IO-min ischemia
37. 0 ± 0. 
37.0 ± 0.1 127 ± 3 36. 5 ± 1. 1 112 ± 4 7AO ± 0.01 13.9 ± 0.2a 10-min ischemia normoglycemia (n = 6) 37. 0 ± 0.1 129 ± 4 37. 2 ± 0. 9 112 ± 2 7. 39 ± 0. 01 7.9 ± 0.5 IO-min ischemia hyperglycemia (n = 6) 37.1 ± 0. 1 135 ± 5 36.9 ± 0.8 118 ± 2 7AO ± 0.01 14.3 ± 0.8e
Values are means ± SEM; n no. of animals. By Newman-Keul's test: ap < 0.01 (ischemia vs. ischemia + dexamethasone); bp < 0.01 (control vs. control + dexamethasone); ep < 0.01 (normoglycemia vs. hyperglycemia).
carotid arteries were clamped. Cessation of EEG activity, which occurred after 10-15 s, was used as an indication of the onset of ischemia. The EEG was monitored inter mittently during and following ischemia. At the end of the ischemia, the shed blood was reinfused, the vascular clamps were removed, and 0.7 ml of an NaHC03 solution (50 mg ml-l ) was administered intravenously. The dura tion of ischemia was 10 min. The N20 supply was discon tinued 15 min following ischemia. At about the same time, the animals could be extubated.
Histopathology
The animals were reanesthetized with halothane and tracheostomized 1 week following ischemia. As will be described below, animals in the chronically pretreated dexamethasone group developed seizures and were pre pared for histopathology when motor seizures were man ifested.
While being mechanically ventilated on 0.6% halothane in a 30% O2-70% N20 gas mixture, the animals were perfusion-fixed via the ascending aorta with 4% formal dehyde buffered to pH 7.35, following a 30-s rinse with 0.9% NaC!. Both solutions were prewarmed to 37°C. The brains were removed and stored in cold fixative. The preparation and the celestine blue-acid fuchsin stain of the brain for histopathological study have been described in detail elsewhere (Auer et aI., 1984a) . One week fol lowing ischemia was chosen as the time for assessment of damage, because then the final neuronal necrosis is fully developed, while resorption of necrotic neurons is not yet extensive. In the staining procedure used, necrotic cells appeared bright red on examination under the light mi croscope (Auer et aI., 1984a, h; Smith et ai, 1984a) , showed extensive cytorrhexis and/or karyorrhexis, and were readily distinguished from surviving neurons.
Quantification of neuronal necrosis
The extent of neuronal necrosis was evaluated as the number of necrotic, acidophilic cells ( Fig. 1) . Counting of such neurons was performed in the caudate nucleus ( Fig.   1A ), parietal cortex (Fig. 1B) , and subiculum, CA l ' CA3, and CA4 sectors of the hippocampus (Fig. 1 C) (Auer et aI., 1984a) . The sections were examined in a blind fashion. A percentage damage score was calculated for the caudate nucleus and the hippocampus. Damage in the parietal cortex was classified according to a crude damage index as follows: 0, no damage; 1, <10% damage; 2, 10-50% damage; 3, >50% damage (Auer et aI., 1984h) . 
Determination of labile energy metabolites and FF As
Samples of the parietal cortex and the hippocampus were dissected out from the brain at -22°C and assayed for metabolites and FFAs according to previously re ported methods (Folbergrova et al., 1972; Rehncrona et aI., 1982) .
Statistical analysis
Results were analyzed using analysis of variance. A post hoc comparison was performed between the experi mental groups using Student's t test, Neuman-Keul's test for multiple comparisons, and the Wilcoxon rank sum test; p values of <0.05 were considered as signifi cant differences.
RESULTS
Physiological variables and EEG
The physiological variables were similar to all ex perimental groups except that plasma glucose con-centration was significantly higher in the chroni cally dexamethasone-treated and the glucose-in fused animals (Table 1) .
EEG characteristics in the ischemic control and drug-treated animals are summarized in Ta ble 2. The pre-and postischemic EEG background (CFM) as well as latency to isoeiectricity were the same in all groups. The latency before the appearance of the first spike following ischemia was significantly shorter in the dexamethasone chronic pretreatment group (p < 0.01).
Histopathological evaluation
All animals with acute pretreatment or chronic posttreatment with dexamethasone survived, and the brain damage was assessed after 7 days of sur vival.
Acute pretreatment of the animals with dexa methasone failed to alter the severity of neuron damage (Fig. 2) . With chronic posttreatment, damage inflicted on the caudate nucleus was ame liorated. Otherwise, chronic posttreatment did not alter the density or the distribution of the damage.
All animals chronically pretreated with dexa methasone developed severe, generalized seizures, and were perfusion-fixed at 18. 7 ± 0. 2 h (mean ± SEM) following ischemia (n = 8). Quantitative analysis showed an increased damage in the subic ulum, CA l ' and CA3 sectors of the hippocampus, in the caudate nucleus, and in the parietal cortex (p < 0. 01 each) (Fig. 2) .
Neither indomethacin nor diclofenac treatment affected the extent of neuronal necrosis (Table 3) .
Energy and glycolytic metabolites
Since dexamethasone administration so dramati cally affected the outcome, tissue metabolites were analyzed before and after 10 min of ischemia. The drug treatment did not affect the values in non ischemic brains, except for the glucose levels, which were increased by 100% in the chronically dexamethasone-pretreated animals. Following 10 min of cerebral ischemia, the total adenylate pool (LAd) and the energy charge (EC) decreased in the parietal cortex ( Fig. 3 ) and in the hippocampus (Fig. 4) in both treated and nontreated groups. In the treated group, the levels of ATP, ADP, LAd, EC, and glycogen were significantly higher (p < 0.05) than in the nontreated group. Furthermore, as a consequence of the higher preischemic glucose concentration, the lactic acid formation during isch emia was significantly enhanced by the chronic dexamethasone treatment in the two brain areas (p < 0.001).
FF A metabolism
Chronic dexamethasone pretreatment did not af fect FFAs in the nonischemic brains. As expected, Values are means ± SEM expressed as percentage acidophilic neurons of the total counted neuronal population, n = no. of animals. Indometh acin (5 mg kg-l 30 min before ischemia) or diclofenac (30 mg kg-l 30 min before and 2 h after ischemia) was administered intravenously.
AB C 0
Cerebral cortex the levels of palmitic acid (16:0), stearic acid (18:0), oleic acid (18: 1), arachidonic acid (20:4), docosahex anoic acid (22:6) ( Fig. 5 ), and total FFAs (Table 4 ) increased during 10 min of ischemia. The FFA levels were significantly lower in the dexametha sone-treated animals in both cortex and hippo campus after 10 min of ischemia. However, no sig nificant differences in the levels of FFA were ob served at 3 min of ischemia (results not shown).
Effect of preischemic plasma glucose concentration on brain metabolism
To explore whether the higher preischemic plasma glucose concentration manifested after chronic dexamethasone pretreatment affects brain metabolism, ischemia was induced under con trolled plasma glucose levels; i.e. , the preischemic plasma glucose concentration was adjusted to the same values that were obtained in the dexametha sone treatment groups by infusion of a 10% glucose solution (Tables 5 and 6 ).
The tissue glucose concentrations in glucose-in fused animals were higher in both cortex (p < 0.001) and hippocampus (p < 0.01) than those in non-glucose-infused ones. However, significant in creases in the level of ATP, EC, glycogen, and lac tate were shown in the hippocampus but not in the parietal cortex (Table 5 ). Furthermore, no signifi cant differences in the FFA levels during ischemia were observed between the two experimental groups (Table 6) . inhibit phospholipase activity via induction of an inhibitory protein called macrocortin (Flower and Blackwell, 1979) or lipomodulin (Hirata et aI. , 1980) . Thus, the significant depression of FFA levels observed in the present investigation fol lowing ischemia in the chronically dexamethasone treated animals as compared with untreated an imals could readily be explained by this mecha nism. The lack of inhibition at 3 min of ischemia suggests that the initial FFA increase might be in duced by other mechanisms, such as via the re ceptor-activated phosphodiesterases and diglyc eride lipases (Berridge, 1984) , not influenced by steroids. This effect also rules out the possibility that the relatively better preserved energy state in J Cereb Blood Flow Metab, Vol. 6, No.4, 1986 these animals could contribute to a more efficient reacylation of the FFAs (Wieloch and Siesj6, 1982) , since such an effect would be expected also at 3 min. This is further substantiated in the experi ments where plasma glucose levels were titrated to 14 f.Lmol g-l . Although the ATP levels and EC were higher in the hippocampus of these animals at 10 min of ischemia, the levels of FFA were not signifi cantly different from those of normoglycemic, isch emic animals. One functional consequence of the lower levels of FFA, and the associated improve ment of cellular energy state could be the rapid re turn of the electrical activity following ischemia ob served in these animals. However, the rapid return of EEG does not necessarily indicate a beneficial effect of the drug. It is recalled that all chronically treated animals had severe seizures not compatible with survival.
DISCUSSION
Tr eatment with cyclooxygenase inhibitors did not have a beneficial effect either. In the doses used in this investigation, indomethacin and diclofenac ef fectively inhibit cyclooxygenase activity in the brain in the postischemic period during which raised FFA concentrations persist (Abdel-Halim et aI., 1978; Riess et aI., 1978; Gaudet et aI., 1980) . The results show that the cyclooxygenase inhib itors do not ameliorate ischemic neuronal damage. If we assume that the drugs per se do not exert deleterious effects on neuronal survival, it seems unlikely that products formed as a result of cy clooxygenase activity contribute to the ischemic brain damage. This corroborates the results pre viously reported by other authors (J(I)rgensen and Diemer, 1982; Capdeville et aI., 1985) .
Adverse effects of chronic dexamethasone pretreatment
The results obtained following administration of dexamethasone are more complex. Acute pretreat- Values are means ± SEM expressed as fLmol g-l wet brain; n = no. of animals.
Statistical comparison was made using Newman-Keul's test: ap < 0.01 (control VS. ischemia); bp < 0.05 (ischemia vs. ischemia + dexametha sone); 'p < 0.01 (ischemia vs. ischemia + dexamethasone). ment with the drug failed to alter the density and/or the distribution of the ischemic damage. Similarly, chronic posttreatment did not decrease the damage in cortical areas. However, it significantly amelio rated the damage inflicted on the caudate nucleus. Since dexamethasone was given post ischemia, its beneficial effects on neuronal survival in the cau date nucleus must be related to events occurring during the first day following ischemia. The results are in contrast to a recent report showing an aggra vation of ischemic neuronal damage, including the caudate nucleus, following postischemic treatment of animals with corticosterone (Sapolsky and Pul sinelli, 1985) . The difference in results is, however, compatible with the reports showing that dexa methasone is retained mainly in glial cells while corticosterone is retained in neurons, suggesting a heterogeneity of steroid receptors with a higher af finity of dexamethasone for glial receptors (Veldhuis et aI., 1982) . If, in addition, dexametha sone treatment decreases the postischemic plasma levels of corticosterone, the ameliorative effect on damage should then increase.
The deleterious effect of chronic pretreatment of animals with dexamethasone could have several ex planations. Prolonged, but not acute, treatment with glucocorticoids has been found to elevate the glucagon concentration in plasma (Marco et aI., 1973; Wise et aI., 1973) . Inasmuch as glucagon it self stimulates gluconeogenesis, the rise in glu cagon should also contribute to hyperglycemia by enhancing synthesis of glucose.
Excessive lactic acidosis is thought to adversely affect recovery following cerebral ischemia (Myers "A 10% glucose solution was infused intravenously to attain desired plasma glucose levels (see Table I ).
By Student's I test: bp < 0.05; cp < 0.001: d p < 0.01 (normoglycemia vs. hyperglycemia).
and Yamaguchi, 1977; Siemkowicz and Hansen, 1978; Myers, 1979; Ginsberg et al. , 1980; Kalimo et aI., 1981; Rehncrona et al. , 1981; Siesjo, 1981) . This offers an explanation for the paradoxical finding that in fed or glucose-infused animals, a trickling cerebral blood flow during incomplete ischemia is more deleterious than complete ischemia (Nord strom et aI. , 1976; Steen et aI., 1979) . Obviously, the nutritional state influences the outcome by af fecting tissue glucose content and/or supply, thereby altering the degree of lactic acidosis. It has been widely assumed that the critical lactic acid concentrations are in the range of 15-25 f,Lmol g-l wet brain (Siesjo, 1981; Gardiner et aI. , 1982; Plum, 1983) . However, it has not been conclusively ex cluded that the effect of the lactic acidosis is a con tinuum rather than a step function, nor is it known if other factors associated with alterations in nutri tional state play a pivotal role (Welsh et aI. , 1980; Pulsinelli et aI. , 1982) .
The marked increase in lactic acidosis in the brain and the enhanced neuronal damage following ischemia in the chronically pretreated group could thus be explained by the elevated plasma glucose levels. However, when glucose was infused to levels similar to those of the dexamethasone treated animals, the cortical lactate content did not reach levels observed in the dexamethasone-treated animals, and there was no effect on the tissue high energy phosphates. Apparently the chronic dexa methasone treatment not only raised the plasma glucose concentration but also affected glucose transport and metabolism during ischemia, possibly by increasing blood flow and/or by enhancing glu cose metabolism. Thus, since dexamethasone has been shown to control glycolytic enzymes such as glyceraldehyde-6-phosphate dehydrogenase in glial cells (De Vellis and Inglish, 1968) , a direct effect of dexamethasone on brain glucose metabolism seems feasible. Another possibility of dexamethasone ef-TABLE 6. Effect of preischemic plasma glucose levels on the free fatty acid concentrations in the parietal cortex and the hippocampus of rats subjected to 10 min of ischemia feet resides in the documented etlecls of corticoste roids on the desensitization of adrenergic (3-re ceptors (Mobley and Sulser, 1980; Mobley et aI., 1983) via an action through the glucocorticoid re ceptors (Meaney and Aitken, 1985) . Thus, chronic pretreatment could desensitize the receptors, thereby mitigating the protective etlect of the locus ceruleus system against ischemic damage (Blom qvist et aI., 1985) . In addition, chronic pretreatment with corticosterone aggravates kainic acid-induced neuronal damage (Sapolsky, 1985) , suggesting that chronic dexamethasone treatment could aggravate ischemic damage via excitotoxic mechanisms (Sa polsky and Pulsinelli, 1985; Wieloch, 1985) .
In conclusion, the present results demonstrate that chronic pretreatment with dexamethasone dra matically aggravates the brain damage incurred by 10 min of reversible ischemia. The effect of the drug is similar to that of preischemic hypergly cemia, which also induces postischemic seizures and aggravated brain damage. Since dexametha sone raises blood glucose concentration and en hances tissue lactic acidosis during ischemia, its adverse effects are, as least in part, due to hyper glycemia. However, the results suggest that chronic dexamethasone treatment has other effects that are harmful to the brain during an ischemic incident.
Provided that the present experimental conditions have their clinical counterparts (Pentelenyi and Kammerer, 1984) , one must caution against the use of dexamethasone in ischemic disease.
